Showing 1 - 13 results of 13 for search 'Clemens A Schmitt', query time: 0.06s
Refine Results
-
1
DLBCL 1L—What to Expect beyond R-CHOP? by Maike Stegemann, Sophy Denker, Clemens A. Schmitt
Published 2022-03-01
Article -
2
-
3
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6) by Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, Michael Hubalek, Edgar Petru, Margit Sandholzer, Johannes Andel, Marija Balic, Thomas Melchardt, Cornelia Hauser-Kronberger, Clemens A. Schmitt, Hanno Ulmer, Richard Greil
Published 2021-10-01
Article -
4
N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness by Hongliang Dong, Lili Zeng, Weiwei Chen, Qian Zhang, Fei Wang, Yan Wu, Bingjie Cui, Jingjing Qi, Xin Zhang, Cuilan Liu, Jiong Deng, Yong Yu, Clemens A. Schmitt, Jing Du
Published 2023-05-01
Article -
5
Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice. by Armin Gerbitz, Madhusudhanan Sukumar, Florian Helm, Andrea Wilke, Christian Friese, Cornelia Fahrenwaldt, Frank M Lehmann, Christoph Loddenkemper, Thomas Kammertoens, Josef Mautner, Clemens A Schmitt, Thomas Blankenstein, Georg W Bornkamm
Published 2012-01-01
Article -
6
Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment by Bernhard Doleschal, Hossein Taghizadeh, Gerald Webersinke, Gudrun Piringer, Georg Schreil, Jörn Decker, Karl J. Aichberger, Patrick Kirchweger, Josef Thaler, Andreas Petzer, Clemens A. Schmitt, Gerald W. Prager, Holger Rumpold
Published 2023-09-01
Article -
7
Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells by Alice Fabarius, Vanessa Samra, Oliver Drews, Handan Mörz, Miriam Bierbaum, Ali Darwich, Christel Weiss, Susanne Brendel, Helga Kleiner, Wolfgang Seifarth, Wolfgang Greffrath, Wolf-Karsten Hofmann, Clemens A. Schmitt, Henning D. Popp
Published 2022-06-01
Article -
8
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry by Florian Huemer, Lukas Weiss, Peter Regitnig, Thomas Winder, Bernd Hartmann, Josef Thaler, Gudrun Piringer, Clemens A. Schmitt, Wolfgang Eisterer, Hannes Gänzer, Alois Wüstner, Johannes Andel, Björn Jagdt, Hanno Ulmer, Richard Greil, Ewald Wöll
Published 2020-03-01
Article -
9
P429: THERAPY-INDUCED SENESCENCE TRIGGERS UPREGULATION OF ANTIGEN PRESENTATION VIA PRC2 INHIBITION AND PROMOTES ANTI-TUMOUR IMMUNITY IN ACUTE MYELOID LEUKAEMIA by Diego Gilioli, Simona Fusco, Teresa Tavella, Kety Giannetti, Anastasia Conti, Santoro Antonella, Edoardo Carsana, Stefano Beretta, Martin Schönlein, Valentina Gambacorta, Federico Aletti, Matteo Giovanni Carrabba, Chiara Bonini, Fabio Ciceri, Ivan Merelli, Luca Vago, Clemens A. Schmitt, Raffaella DI Micco
Published 2023-08-01
Article -
10
H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients by Kolja Schleich, Julia Kase, Jan R. Dörr, Saskia Trescher, Animesh Bhattacharya, Yong Yu, Elizabeth M. Wailes, Dorothy N. Y. Fan, Philipp Lohneis, Maja Milanovic, Andrea Lau, Dido Lenze, Michael Hummel, Bjoern Chapuy, Ulf Leser, Maurice Reimann, Soyoung Lee, Clemens A. Schmitt
Published 2020-07-01
Article -
11
P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM-02) by Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Christoph Tinchon, Niklas Zojer, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Woell, Reinhard Ruckser, Boris Bozic, Maria Theresa Krauth, Andreas Petzer, Clemens A. Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Bruno Paiva, Richard Greil
Published 2023-08-01
Article -
12
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I by Johannes Brägelmann, Carina Lorenz, Sven Borchmann, Kazuya Nishii, Julia Wegner, Lydia Meder, Jenny Ostendorp, David F. Ast, Alena Heimsoeth, Takamasa Nakasuka, Atsuko Hirabae, Sachi Okawa, Marcel A. Dammert, Dennis Plenker, Sebastian Klein, Philipp Lohneis, Jianing Gu, Laura K. Godfrey, Jan Forster, Marija Trajkovic-Arsic, Thomas Zillinger, Mareike Haarmann, Alexander Quaas, Stefanie Lennartz, Marcel Schmiel, Joshua D’Rozario, Emily S. Thomas, Henry Li, Clemens A. Schmitt, Julie George, Roman K. Thomas, Silvia von Karstedt, Gunther Hartmann, Reinhard Büttner, Roland T. Ullrich, Jens T. Siveke, Kadoaki Ohashi, Martin Schlee, Martin L. Sos
Published 2021-09-01
Article -
13
The genomic and transcriptional landscape of primary central nervous system lymphoma by Josefine Radke, Naveed Ishaque, Randi Koll, Zuguang Gu, Elisa Schumann, Lina Sieverling, Sebastian Uhrig, Daniel Hübschmann, Umut H. Toprak, Cristina López, Xavier Pastor Hostench, Simone Borgoni, Dilafruz Juraeva, Fabienne Pritsch, Nagarajan Paramasivam, Gnana Prakash Balasubramanian, Matthias Schlesner, Shashwat Sahay, Marc Weniger, Debora Pehl, Helena Radbruch, Anja Osterloh, Agnieszka Korfel, Martin Misch, Julia Onken, Katharina Faust, Peter Vajkoczy, Dag Moskopp, Yawen Wang, Andreas Jödicke, Lorenz Trümper, Ioannis Anagnostopoulos, Dido Lenze, Ralf Küppers, Michael Hummel, Clemens A. Schmitt, Otmar D. Wiestler, Stephan Wolf, Andreas Unterberg, Roland Eils, Christel Herold-Mende, Benedikt Brors, ICGC MMML-Seq Consortium, Reiner Siebert, Stefan Wiemann, Frank L. Heppner
Published 2022-05-01
Article